Page 3 - Aspire Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aspire capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aspire Capital Today - Breaking & Trending Today

Marker Therapeutics Reports Fiscal Year 2020 Operating and Financial Results


Marker Therapeutics Reports Fiscal Year 2020 Operating and Financial Results
- Dosed first patient in the Company s Phase 2 trial of MT-401, its lead MultiTAA-specific T cell product candidate, for the treatment of post-transplant acute myeloid leukemia -
- Completed construction of new in-house cGMP manufacturing facility in Houston to supply MultiTAA-specific T cell products, including MT-401, for clinical activities and potential commercialization; facility expected to be fully operational in 1H 2021 -
News provided by
Share this article
Share this article
HOUSTON, March 9, 2021 /PRNewswire/  Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today provided a corporate update and reported financial results for the fiscal year ended December 31, 2020.   ....

United States , Peterl Hoang , Marker Therapeutics Inc , Capital Fund , Marker Therapeutics , Multi Antigen Targeted , Specifict Cell Product Candidate , George Bush Intercontinental , Aspire Capital Fund , Aspire Capital , Private Securities Litigation Reform Act , Operating Activities , Investing Activities , Financing Activities , Health Care Amp Hospitals , Medical Pharmaceuticals , ஒன்றுபட்டது மாநிலங்களில் , மார்க்கர் சிகிச்சை இன்க் , மூலதனம் நிதி , மார்க்கர் சிகிச்சை , ஜார்ஜ் புஷ் கண்டம் , ஆசை மூலதனம் நிதி , ஆசை மூலதனம் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் , இயங்குகிறது நடவடிக்கைகள் , முதலீடு நடவடிக்கைகள் ,